Molecular-Biological Methods of Quality Control of Biological Active Substances Produced by Recombinant DNA Technology
Biotechnological products manufactured by recombinant DNA technology are widely used nowadays. According to the national and international requirements the amount of residual host cell DNA in such products should not exceed 10 ng per dose. However, for products intended for frequent or long-term...
|Main Authors:||, , , , ,|
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
|Series:||Биопрепараты: Профилактика, диагностика, лечение|